NanoHarmonics acquires Avagen Pharma

By The Science Advisory Board staff writers

March 30, 2022 -- Biodiagnostic device company NanoHarmonics has acquired Avagen Pharma, a global distributor of a product that utilizes an advanced drug delivery system to treat premature ejaculation.

For NanoHarmonics, the deal furthers its goal of integrating drug delivery systems, according to the vendor. Its current pipeline includes pain medications and drugs for malaria, tuberculosis, and other infectious diseases, including COVID-19.

Terms of the acquisition were not disclosed.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.